Veracode Research Reveals 80% of Applications Developed in EMEA Contain Security Flaws
Veracode, a leading global provider of intelligent software security, today released research indicating applications developed by organisations in Europe, Middle East and Africa tend to contain more security flaws than those created by their U.S. counterparts. Across all regions analysed, EMEA also has the highest percentage of ‘high severity’ flaws, meaning they would cause a critical issue for the business if exploited. High numbers of flaws and vulnerabilities in applications correlate with increased levels of risk, which is particularly notable as software supply chain cyberattacks dominate headlines in 2023.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230925296799/en/
Figure 1: Percent of applications that had a flaw found in their last scan over the last 12 months, by category. Lower numbers are better. (Graphic: Business Wire)
Researchers found that just over 80 percent of applications developed by EMEA organisations had at least one security flaw detected in their most recent scan over the last 12 months, compared to just under 73 percent of U.S. organisations. In addition, the percentage of applications containing ‘high severity’ flaws was the highest of all regions, at almost 20 percent.
“Our data shows that organisations globally are continuing to deploy a worrying number of applications with a high number of flaws in the CWE Top 25,” said Chris Eng, Chief Research Officer at Veracode. “We did, however, identify interesting regional differences, particularly in terms of third-party or open-source code usage and the ways in which vulnerabilities are introduced across the application lifecycle,” he continued.
Analysis of data collected from more than 27 million scans across 750,000 applications helped to produce Veracode’s latest annual report on the State of Software Security. This new report showcases the EMEA-specific findings from those scans and applications, including results from UK, Germany, France, Italy and across the Middle East and Africa.
Numbers alone don’t convey the consequences of hackers exploiting software vulnerabilities. With organisations across EMEA utilising an ever more complex mix of third-party software to deliver their services, the exploitation of a serious vulnerability can impact thousands of victims at once. Earlier this year, a vulnerability affecting printing software tools PaperCut MF and PaperCut NG was actively abused by threat actors. Up to 70,000 organisations in 200 countries became potential victims, and law enforcement reports found threat actors successfully compromised vulnerable entities in the education sector.
Java and Third-party Code Introduce Significant Security Flaws
The research identified notable regional differences in preferred language usage, with Java revealed to be the preferred language for developers in EMEA. Teams using Java were found to remediate flaws at a slower rate than those using .NET or JavaScript, causing many of these flaws to persist or remain undiscovered for significantly longer. Moreover, as over 95 percent of Java applications are comprised of third-party or open-source code, Java usage is a key factor in the higher percentage of vulnerabilities introduced into applications in the region. This highlights the importance of software composition analysis (SCA), which picks up flaws in open-source code, and the research found a higher proportion of flaws reported by SCA in EMEA than in other regions.
As generative AI continues to gain strong traction in software development, the risk of vulnerabilities from external sources increases. A study, presented at Black Hat in 2022, showed vulnerabilities in 40 percent of code that had been written by large language models trained on vast troves of unrefined data, including millions of public GitHub repositories. It is therefore vital organisations leverage SCA tools to find and fix flaws, empowering developers to take advantage of AI without compromising the security of applications.
Applications Become More Vulnerable Over Time
The research also showed new flaws continue to be introduced into EMEA applications at a far higher rate across the entire application lifecycle than in other regions. While EMEA organisations keep updating applications, there was less of a focus on quality. After a five-year timespan, 50 percent of applications in EMEA continue to introduce new flaws, compared to just over 30 percent for the rest of the world. Overall, the baseline chance that a flaw will be introduced in any given month was 27 percent.
As such, EMEA organisations would benefit from paying more attention to the latter portion of the application lifecycle and scanning applications more regularly. They should also prioritise security training for developers, with the research finding completion of 10 interactive security labs reduces the probability of flaw introduction from 27 percent to about 25 percent in any given month.
“This year’s State of Software Security report shines a light on the importance of security across the entire software lifecycle, as well as the urgent need to address risks posed by third-party and AI-generated code,” Eng added. “Whilst across the board globally we are still seeing a concerning volume of vulnerabilities, these figures are higher in EMEA across almost all measurements. Development teams in this region must take the opportunity to automate software security for regular scanning, and carefully consider their use of AI tools, both to increase security and empower developers.”
The Veracode State of Software Security EMEA 2023 recommends four actions software development teams can take to improve their cybersecurity posture and is available to download on the Veracode website.
The global Veracode State of Software Security 2023 report is available to download.
About the State of Software Security Report
The 13th volume of Veracode’s annual report on the State of Software Security examines historical trends shaping the software landscape and how security practices are evolving along with those trends. This year’s findings are based on the full historical data available from Veracode services and customers and represent a cross-section of large and small companies, commercial software suppliers, software outsourcers, and open-source projects. The report contains findings about applications that were subjected to static analysis, dynamic analysis, software composition analysis, and/or manual penetration testing through Veracode’s cloud-based platform.
About Veracode
Veracode is intelligent software security. The Veracode Software Security Platform continuously detects flaws and vulnerabilities at every stage of the modern software development lifecycle. Prompted by powerful AI trained by trillions of lines of code, Veracode customers fix flaws faster with high accuracy. Trusted by security teams, developers, and business leaders from thousands of the world’s leading organisations, Veracode is the pioneer, continuing to redefine what intelligent software security means.
Copyright © 2023 Veracode, Inc. All rights reserved. Veracode is a registered trademark of Veracode, Inc. in the United States and may be registered in certain other jurisdictions. All other product names, brands or logos belong to their respective holders. All other trademarks cited herein are property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230925296799/en/
Contact information
Katy Gwilliam
kgwilliam@veracode.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical added to membership of Russell 3000 ® Index28.6.2025 02:30:00 EEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 23:44:00 EEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 17:00:00 EEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 15:00:00 EEST | Press release
To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet this manual process demands significant time and effort and can lead to inconsistent results,” said Dr. A
Pure Lithium Founder & CEO Emilie Bodoin Recognized for Trailblazing Woman of the Year at 2025 Volta Foundation Awards at 17 th Annual Fastmarkets Lithium Supply and Battery Raw Materials Conference27.6.2025 13:00:00 EEST | Press release
Pure Lithium Corporation, a disruptive vertically integrated lithium metal battery technology company, is pleased to announce that its Founder, Chairman & CEO, Emilie Bodoin received special recognition for Trailblazing Woman of the Year Award Sponsored by ExxonMobil at the 2025 Fastmarkets Volta Awards Ceremony, in Las Vegas, Nevada on June 24. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627170164/en/ This award celebrates an exceptional female leader who has demonstrated outstanding leadership, vision, and impact within her industry. It recognizes achievements in driving innovation, fostering diversity, and inspiring others while making significant contributions to her organization. “I am truly honored to receive special recognition for this award. One of the best things about my role is the opportunity to lead by example and encourage and inspire women and girls who may not yet recognize their potential. To all of m
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom